Sensorcaine (BUPIVACAINE HYDROCHLORIDE)
Sensorcaine (BUPIVACAINE HYDROCHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Sensorcaine; Generic name: BUPIVACAINE HYDROCHLORIDE; Manufacturer: Henry Schein, Inc..
| Brand name | Sensorcaine |
|---|---|
| Generic name | BUPIVACAINE HYDROCHLORIDE |
| Manufacturer | Henry Schein, Inc. |
| Used for | INDICATIONS & USAGE Sensorcaine (bupivacaine HCl) is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see WARNINGS). Experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of the 0.75% concentration of bupivacaine HCl in these patients. Sensorcaine is not recommended for intravenous regional anesthesia (Bier Block) (see WARNINGS). The routes of administration and indicated Sensorcaine concentrations are: Standard textb |
| Dosage | DOSAGE & ADMINISTRATION The dose of any local anesthetic administered varies with the anesthetic procedure, the area to be anesthetized, the vascularity of the tissues, the number of neuronal segments to be blocked, the depth of anesthesia and degree of muscle relaxation required, the duration of anesthesia desired, individual tolerance, and the physical condition of the patient. The smallest dose and concentration required to produce the desired result should be administered. Dosages of Sensorc |
| Warnings | WARNINGS Methemoglobinemia : Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthe |
| Active ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
| Route | PERINEURAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=100201ad-6e4d-4e91-8b5c-621d0bf0dcc2 |